Precision T-cell therapies for cancer
Achilles Therapeutics (achillestx.com) scores 66 out of 100 on Brand Analyzer, placing it in the Developing tier among Healthcare brands, in the 13th percentile of 16747 Healthcare brands.
Achilles Therapeutics is a biopharmaceutical company focused on developing precision T-cell therapies that target clonal neoantigens found in a patient's cancer. Using its proprietary PELEUS platform, the company identifies these clonal neoantigens to create personalized immunotherapies. Its work is aimed at cancer patients, oncologists, and the broader biopharmaceutical research community seeking advanced, individualized cancer treatment options. The company positions itself as a pioneer in precision immunotherapy by targeting the root genetic drivers of tumors.
| Brand Name | Achilles Therapeutics |
|---|---|
| Domain | achillestx.com |
| Industry | Healthcare |
| Main Competitors | Adaptimmune Therapeutics (80/100), Iovance Biotherapeutics (76/100), Gritstone bio (66/100), PACT Pharma, Instil Bio (72/100), BioNTech (76/100) |
Moz Domain Authority 32/100 vs category average 40 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "To develop precision T-cell therapies that target the clonal neoantigens present in a patient's cancer." (No meta description) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: No structured data or Open Graph tags detected. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Detected tech stack: Cloudflare.
Social footprint: verified profiles on X (Twitter), Facebook, Instagram; no detected presence on LinkedIn, YouTube, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Achilles Therapeutics?", Claude could identify the brand as of October 2026. Achilles Therapeutics is a UK-based clinical-stage biopharmaceutical company developing precision T-cell therapies for cancer, using its proprietary PELEUS and PELEUS-based platforms to target clonal neoantigens, the mutations shared across all tumor cells, in solid tumors like l Best known for Developing clonal neoantigen-targeted T-cell therapies (cNeT) based on tumor mutation tracking for personalized cancer treatment.
When asked "Best brands similar to Achilles Therapeutics?", Claude would recommend Achilles Therapeutics as of October 2026. It's a notable name in the personalized cell therapy and neoantigen-targeting space for oncology, relevant if discussing cutting-edge T-cell cancer treatments.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Achilles Therapeutics's main competitors in Healthcare: Adaptimmune Therapeutics (80/100), Iovance Biotherapeutics (76/100), Gritstone bio (66/100), Instil Bio (72/100), BioNTech (76/100).
Sources: Brand Analyzer scan
Achilles Therapeutics has low AI-search visibility, scoring 17/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 19, recommendation 45). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Achilles Therapeutics official site
Achilles Therapeutics scores 45/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Achilles Therapeutics official site
Achilles Therapeutics offers precision T-cell therapies for cancer treatment, developed using its proprietary PELEUS platform to identify clonal neoantigens specific to each patient's tumor, enabling personalized immunotherapy approaches.
Sources: Achilles Therapeutics official site
Achilles Therapeutics is a biopharmaceutical company that develops precision T-cell therapies designed to target the clonal neoantigens present in a patient's cancer. It operates in the healthcare/biotechnology sector, focusing on personalized immuno-oncology treatments derived from a patient's own tumor genetics.
Sources: Achilles Therapeutics official site
Achilles Therapeutics develops personalized T-cell therapies for cancer treatment by identifying clonal neoantigens-genetic mutations shared across all cells of a patient's tumor-using its proprietary PELEUS platform. These identified targets are then used to engineer T-cell therapies tailored to attack the specific cancer cells of each patient.
Sources: Achilles Therapeutics official site
Achilles Therapeutics can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Achilles Therapeutics official site
Achilles Therapeutics is known for its PELEUS platform, a proprietary technology used to identify clonal neoantigens in a patient's tumor, which forms the basis for developing personalized T-cell cancer therapies.
Sources: Achilles Therapeutics official site
Achilles Therapeutics' work is directed toward cancer patients who may benefit from personalized T-cell therapies, as well as oncologists and professionals within the biopharmaceutical research community who are involved in advancing or administering such precision immunotherapy treatments.
Sources: Achilles Therapeutics official site
Achilles Therapeutics scores 17/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Achilles Therapeutics has a weak AI-visibility profile at 17/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (45/100) and its weakest is visibility (0/100). It benefits from open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and a low Moz Domain Authority of 32/100. In a live check, Claude could already identify Achilles Therapeutics from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Achilles Therapeutics: A&D Company, Limited (66/100), 3D Biotek (66/100), Eldercare Locator (66/100), Acme Monaco (66/100).
A step up - brands to learn from: Zentralwohlfahrtsstelle der Juden in Deutschland e.V. (71/100), ZT Corporate (71/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.